News
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
22 Apr 24
Analyst Ratings
Mizuho Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $96
22 Apr 24
News, Price Target, Analyst Ratings
How Is The Market Feeling About Intra-Cellular Therapies?
19 Apr 24
Short Sellers, Short Ideas, Trading Ideas
Reported Earlier, Intra-Cellular Therapies Prices Public Offering Of 6,849,316 Common Shares At $73/Share
18 Apr 24
News
Goldman Sachs Maintains Neutral on Intra-Cellular Therapies, Raises Price Target to $77
17 Apr 24
News, Price Target, Analyst Ratings
B of A Securities Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $91
17 Apr 24
News, Price Target, Analyst Ratings
Baird Maintains Outperform on Intra-Cellular Therapies, Raises Price Target to $103
17 Apr 24
News, Price Target, Analyst Ratings
TD Cowen Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $90
17 Apr 24
News, Price Target, Analyst Ratings
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
17 Apr 24
Earnings, News, Penny Stocks, Pre-Market Outlook, Markets, Trading Ideas
Intra-Cellular Therapies Announces $500M Proposed Public Offering Of Common Stock
16 Apr 24
News, Offerings
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
16 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Intraday Session
16 Apr 24
Movers
Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study
16 Apr 24
Biotech, News, Health Care, Previews, Trading Ideas, General
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
16 Apr 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Market-Moving news for April 16th
16 Apr 24
Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
16 Apr 24
Movers
Needham Reiterates Buy on Intra-Cellular Therapies, Maintains $82 Price Target
16 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Intra-Cellular Reports Phase 3 Topline Results From Study 501 Evaluating Lumateperone As Adjunctive Therapy In Patients With Major Depressive Disorder; Lumateperone 42 Mg Met The Primary Endpoint
16 Apr 24
News
Needham Reiterates Buy on Intra-Cellular Therapies, Maintains $82 Price Target
5 Apr 24
News, Price Target, Reiteration, Analyst Ratings
10 Health Care Stocks Whale Activity In Today's Session
4 Apr 24
Options
Press releases
Intra-Cellular Therapies Prices Public Offering of Common Stock
17 Apr 24
Press Releases
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
16 Apr 24
Markets, Press Releases
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
16 Apr 24
Press Releases
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
19 Mar 24
News, Management, Press Releases
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
6 Mar 24
News, Press Releases
Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
27 Feb 24
News, Press Releases
Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
22 Feb 24
Earnings, Press Releases
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
8 Feb 24
News, Press Releases